Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest Under Debentures Jul 28, 2017
Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions May 18, 2017
Acasti Granted Additional Composition & Use Patents in Taiwan and Australia; Safeguards Valuable Market Expansion Opportunities Apr 24, 2017
Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions Apr 12, 2017
